Skip to main content
Clinical Trials/TCTR20240328002
TCTR20240328002RecruitingPhase 1

A randomized crossover study on the effect of train-of-four monitoring with clinical assessment vs clinical assessment alone on continuous neuromuscular blockade dose in pediatric intensive care patients

Dr. Suvikrom Law0 sites18 target enrollmentStarted: March 28, 2024Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor
Enrollment
18

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
1 Months to 18 Years (—)
Sex
All

Inclusion Criteria

  • 1. Patients admitted to PICU
  • 2. Plan to receive continuous IV cisatracurium infusion for at least 2 days

Exclusion Criteria

  • 1. Known or suspected neuromuscular disease
  • 2. Fracture of both hands or wrists
  • 3. Allergic to cisatracurium or atracurium
  • 4. Patient having medical devices on both hands that preclude TOF testing
  • 5. Patient having permanent or temporary cardiac pacemaker

Investigators

Sponsor
Dr. Suvikrom Law

Similar Trials